http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-291762-A5

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9086b819d0a36a336342ea3a75ca4c38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
filingDate 1990-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3df2cf22037f5160d760afe2ca3a76ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8abcb9dd30c0694a37c282e560f00e73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dc8cae68bd9a591c6f2d82677c2e0ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06e6de3c92c6fb668973164919fca6c3
publicationDate 1991-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-291762-A5
titleOfInvention PROCESS FOR PREPARING 2- (1,3,4-THIADIAZOL-2-YL) CHINOXALINES
abstract The invention relates to a process for the preparation of previously not available * (formula I), which are applicable as intermediates for the preparation of biologically active preparations. The synthesis is carried out by reacting quinoxaline-2-dithiocarboxylic acid esters with aliphatic, aromatic or heterocyclic carboxylic acid hydrazides. {* Quinoxaline; * Quinoxaline-2-dithiocarboxylic acid ester; carboxylic acid hydrazides; cyclization}
priorityDate 1990-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421344561
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID651711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426705064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426705065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415718431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426705066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420303776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426705067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15055365
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID651711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426705068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15055366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426705069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15055367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413310015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426705070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11355473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15055371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15055374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15055375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414092084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15055376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413177789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426176739

Total number of triples: 50.